• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

Trendingnow

1

'Dr. Doom' Nouriel Roubini says we're headed for universal basic income or 'some form of socialism' as AI revolutionizes work—He calls that optimistic

2

Power companies are using eminent domain to seize land for data centers as 70% of Americans say not in my backyard

3

‘I want to die broke’: Billionaire philanthropist Denny Sanford dies after giving away $4 billion

1

'Dr. Doom' Nouriel Roubini says we're headed for universal basic income or 'some form of socialism' as AI revolutionizes work—He calls that optimistic

2

Power companies are using eminent domain to seize land for data centers as 70% of Americans say not in my backyard

3

‘I want to die broke’: Billionaire philanthropist Denny Sanford dies after giving away $4 billion
Healthobesity

How drugs like Ozempic and Wegovy work for weight loss: ‘Food tastes good, but I don’t want it’

By
Rachel Reiff Ellis
Rachel Reiff Ellis
Down Arrow Button Icon
By
Rachel Reiff Ellis
Rachel Reiff Ellis
Down Arrow Button Icon
July 1, 2023, 9:15 AM ET
Getty Images
Add Fortune on Google for similar content.

For the scores of people seeing weight loss success on prescription injectables such as Ozempic, Wegovy, Saxenda, and others, the number on the scale isn’t the only change they’re experiencing. The “food noise” in their brains—the mental distraction of feeling compelled to eat—is also getting quieter.

Recommended Video

Robin, 49, from Baltimore, who is using her first name for privacy, started taking Ozempic in December of 2022 as a preventative measure against diabetes after she showed several signs of insulin resistance. Since then, she’s lost 20 pounds, her blood sugar and blood pressure have both stabilized—and her relationship to food has completely changed.

“I joke that the drug has taken away my last vices,” she says. “Food tastes good, but I don’t want it. I don’t crave anything, and sometimes I have to force myself to eat. The losing weight is awesome—the drug has definitely improved my numbers, like it was supposed to do. But it makes me a little sad since I enjoy food.”

So how exactly are these drugs hijacking the brain space formerly occupied by the siren song of snacks? By acting like chemical messengers and telling your brain you’re full.

How Ozempic and Wegovy work

Ozempic and Wegovy are in a class of drugs called glucagon-like peptide-1 agonists, or GLP-1 agonists. GLP-1 is a hormone your body makes naturally, one of several that helps regulate your appetite. It also decreases gastric emptying time, meaning food passes through your gut much more slowly, and stimulates and improves the release of insulin, which helps manage your blood sugar.

An agonist is a substance that binds to a receptor (a molecule that receives a signal) on or in a cell and causes the same action as the substance that normally binds to the receptor. In other words, these drugs act like the natural hormone GLP-1 and make your cells’ receptors send the exact same signal they would if they were binding to GLP-1 itself.

“It’s essentially hormone replacement for the hunger satiety signaling system that everyone has in their body that is supposed to regulate weight,” says Dr. Lydia Alexander, president-elect of the Obesity Medicine Association and chief medical officer for Enara Health. “When weight isn’t regulated properly by the body, we have obesity.”

How Ozempic and Wegovy quiet ‘food noise’

The GLP-1 your body makes gets degraded fairly quickly, but GLP-1 agonists stimulate their receptors for far longer. These receptors are in several different places in your body such as the gut and the liver, but the primary place of action is the brain, says Dr. Nisha Patel, obesity medicine specialist with Sutter Health in San Francisco.

“The body has mechanisms in place that are trying to fight that weight loss,” she says. “They’re saying, ‘No, I don’t really like this. I’m going to make you hungrier. I’m going to make it easier for you to want to see food.’ And so the medications are really there to help level the playing field, offset those changes that are happening, and make it easier for people to stick with healthy habits.”

But Patel emphasizes it’s not a quick fix—the medication is dosed upward slowly over several months—and for some people, it’s not a fix at all.

“There’s a lot of individual variability,” she says. “Not everybody responds as robustly. Some people don’t lose weight at all, and in fact, they gain weight. The lifestyle piece of it is still a very important foundation of our care. But medications are a really great tool for our patients to help them improve their health.”

Willpower doesn’t treat obesity

Many people are genetically predisposed to a deficiency in or resistance to GLP-1, which means they don’t get the same signals that other people get. It’s much harder for your body to regulate its hunger-satiety system when this is the case. But contrary to some societal messaging, the solution isn’t just to “try harder,” says Alexander.

“It feels as though it should be very simple, that if we just controlled ourselves a bit more and have more willpower, that we would get on top of this,” she says. “But this is a chronic relapsing condition, and our hormones are driving our behavior.”

It’s behavior human bodies have needed to survive, especially 10,000 years ago when food was scarce, says Alexander. But today, they’re sent for the wrong reason, creating a vicious circle.

“It becomes maddening—you reduce your weight and you’re feeling great about it, but the more you reduce your weight, the further away you get from your weight set point, which increases these signals, driving their behavior to go back and eat. And this is what ends up feeling like a personal failing, because you’re arm wrestling with your hormones, and they’re going to win.”

When combined with lifestyle changes, Ozempic and other drugs are highly effective for many people who take them, resulting in around 15% body weight loss on average. It’s a weight not only off their frame, but for many, their mind, too.

“Especially for my patients that have reward-seeking behavior and cravings, they’re not feeling like they’re constantly having to struggle and fight urges,” says Patel. “It’s pretty liberating.”

The Fortune 500 Innovation Forum will convene Fortune 500 executives, U.S. policy officials, top founders, and thought leaders to help define what’s next for the American economy, Nov. 16-17 in Detroit. Apply here.
About the Author
By Rachel Reiff Ellis
See full bioRight Arrow Button Icon
Add Fortune on Google for similar content.

Latest in Health

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Health

Ferran Torres
SuccessWorld Cup
Spain’s Ferran Torres scored the winning goal in the World Cup—but just four years ago, he was in therapy and stuck in a ‘bottomless pit’
By Emma BurleighJuly 20, 2026
4 hours ago
FDA walks back positive lab test while lettuce recall continues
HealthFood and drink
FDA walks back positive lab test while lettuce recall continues
By Bloomberg, Kristina Peterson, Jessica Nix and Daniela SirtoriJuly 20, 2026
5 hours ago
Pharmacy technician Brandy Leroy fills a TPN bag using the ExactaMix Pro Automated Compounding System
Startups & VentureTerm Sheet
The FDA’s peptide vote could create telehealth’s next multibillion-dollar market
By Lily Mae LazarusJuly 20, 2026
8 hours ago
A decade after the ‘Godfather of AI’ said radiologists were obsolete, their salaries are up to $571K and demand is growing fast
AIthe future of work
A decade after the ‘Godfather of AI’ said radiologists were obsolete, their salaries are up to $571K and demand is growing fast
By Marco Quiroz-GutierrezJuly 19, 2026
1 day ago
How United’s ‘premiumization’ strategy got passengers to swallow higher airfares without a fight
HealthAirline industry
How United’s ‘premiumization’ strategy got passengers to swallow higher airfares without a fight
By Phil WahbaJuly 19, 2026
2 days ago
Diarrhea-causing lettuce may have spread as wide as 27 states, Taylor Farms recall suggests
HealthFood and drink
Diarrhea-causing lettuce may have spread as wide as 27 states, Taylor Farms recall suggests
By Savannah Peters and The Associated PressJuly 18, 2026
2 days ago

Most Popular

'Dr. Doom' Nouriel Roubini says we're headed for universal basic income or 'some form of socialism' as AI revolutionizes work—He calls that optimistic
AI
'Dr. Doom' Nouriel Roubini says we're headed for universal basic income or 'some form of socialism' as AI revolutionizes work—He calls that optimistic
By Jason MaJuly 18, 2026
2 days ago
Power companies are using eminent domain to seize land for data centers as 70% of Americans say not in my backyard
AI
Power companies are using eminent domain to seize land for data centers as 70% of Americans say not in my backyard
By Aaron Walayat and The ConversationJuly 19, 2026
1 day ago
‘I want to die broke’: Billionaire philanthropist Denny Sanford dies after giving away $4 billion
Success
‘I want to die broke’: Billionaire philanthropist Denny Sanford dies after giving away $4 billion
By Sydney LakeJuly 20, 2026
6 hours ago
Red Lobster’s 37-year-old CEO waited tables before joining the C-suite—he says it was a crash course in managing ‘difficult people and situations’
Success
Red Lobster’s 37-year-old CEO waited tables before joining the C-suite—he says it was a crash course in managing ‘difficult people and situations’
By Preston ForeJuly 19, 2026
2 days ago
Warren Buffett says his $147 billion investing career was an accident: ‘I may be one of the 10 luckiest in the world’
Future of Work
Warren Buffett says his $147 billion investing career was an accident: ‘I may be one of the 10 luckiest in the world’
By Sarah GlodekJuly 20, 2026
13 hours ago
It’s not just Taco Bell lettuce and possible glass in Pillsbury rolls: Food and drink recall events reached a 6-year year-over-year high
Retail
It’s not just Taco Bell lettuce and possible glass in Pillsbury rolls: Food and drink recall events reached a 6-year year-over-year high
By Sasha RogelbergJuly 20, 2026
10 hours ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.